Cardiex Ltd
ASX:CDX

Watchlist Manager
Cardiex Ltd Logo
Cardiex Ltd
ASX:CDX
Watchlist
Price: 0.034 AUD -5.56% Market Closed
Market Cap: 18.7m AUD

Operating Margin

-334.5%
Current
Declining
by 85.4%
vs 3-y average of -249.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-334.5%
=
Operating Income
AU$-11.9m
/
Revenue
AU$3.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-334.5%
=
Operating Income
AU$-11.9m
/
Revenue
AU$3.6m

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Cardiex Ltd
ASX:CDX
18.7m AUD
Loading...
US
Abbott Laboratories
NYSE:ABT
212.2B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.9B USD
Loading...
US
Stryker Corp
NYSE:SYK
137.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
136B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.4B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.4B EUR
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58B USD
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.1B USD
Loading...
No Stocks Found

Market Distribution

In line with most companies in Australia
Percentile
34rd
Based on 3 951 companies
34rd percentile
-334.5%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Cardiex Ltd
Glance View

Market Cap
18.7m AUD
Industry
Health Care

CardieX Ltd. is engaged in the designing, manufacturing, and marketing of medical devices for use in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm is focused on designing, manufacturing and marketing medical devices for use in cardiovascular health management. The company operates through its subsidiaries, including ATCOR and CONNEQT. The firm's ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its FDA-cleared and patented SphygmoCor technology. Under the ATCOR.X brand, the Company also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. The firm's digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients' health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness and wellness parameters.

CDX Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-334.5%
=
Operating Income
AU$-11.9m
/
Revenue
AU$3.6m
What is Cardiex Ltd's current Operating Margin?

The current Operating Margin for Cardiex Ltd is -334.5%, which is below its 3-year median of -249.1%.

How has Operating Margin changed over time?

Over the last 3 years, Cardiex Ltd’s Operating Margin has decreased from -257.9% to -334.5%. During this period, it reached a low of -404.8% on Dec 31, 2024 and a high of -36.6% on Dec 31, 2023.

Back to Top